Real-world homologous recombination repair (HRR) mutation testing patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in the United States (US).

被引：0
|
作者：
Barata, Pedro C.
Montgomery, Rachel
Last, Matthew
Gillespie-Akar, Liane
Nazari, Jonathan
Niyazov, Alexander
机构：
[1] Tulane Univ, New Orleans, LA USA
[2] Adelphi Real World, Bollington, England
[3] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world economic burden of patients with metastatic castration-sensitive prostate cancer (mCSPC)
    Kaye, Deborah
    Khilfeh, Ibrahim
    Muser, Erik
    Morrison, Laura
    Urosevic, Ana
    Kinkead, Frederic
    Lefebvre, Patrick
    Pilon, Dominic
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 64 - 64
  • [2] Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study
    Tagawa, S. T.
    Sandin, R.
    Sah, J.
    Mu, Q.
    Freedland, S. J.
    ANNALS OF ONCOLOGY, 2020, 31 : S541 - S542
  • [3] Real world (rw) homologous recombination repair (HRR) gene mutation testing trends in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the United States (US).
    Barata, Pedro C.
    Montgomery, Rachel
    Last, Matthew
    Gillespie-Akar, Liane
    Nazari, Jonathan
    Arondekar, Bhakti
    Niyazov, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Real-world homologous recombination repair mutation (HRRm) testing patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib in the United States
    George, Daniel J.
    Kariburyo-Yay, Furaha
    Aggarwal, Himani
    Tepsick, Jon G.
    Yu, Rebekah
    Li, Weiyan
    McLaurin, Kimmie K.
    Orji, Chinelo
    Lal, Lincy S.
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 332 - 332
  • [5] Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States
    Ryan, Charles J.
    Ke, Xuehua
    Lafeuille, Marie-Helene
    Romdhani, Hela
    Kinkead, Frederic
    Lefebvre, Patrick
    Petrilla, Allison
    Pulungan, Zul
    Kim, Seung
    D'Andrea, Denise M.
    Francis, Peter
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2021, 206 (06): : 1420 - 1429
  • [6] Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States
    Schiff, Howard I.
    JOURNAL OF UROLOGY, 2022, 207 (04): : 939 - 939
  • [7] Real-world (RW) prevalence of adverse events (AEs) among patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC).
    Swami, Umang
    Xie, Bin
    Ramaswamy, Krishnan
    El-Chaar, Nader N.
    Gao, Wei
    Yang, Hongbo
    Wang, Yao
    Young, Christopher
    Mucha, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [8] Survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study.
    Freedland, Stephen J.
    Sandin, Rickard
    Sah, Janvi
    Emir, Birol
    Mu, Qiao
    Ratiu, Anna
    Hong, Agnes
    Serfass, Lucile
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States
    Kaye, Deborah R.
    Khilfeh, Ibrahim
    Muser, Erik
    Morrison, Laura
    Kinkead, Frederic
    Lefebvre, Patrick
    Pilon, Dominic
    George, Daniel
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 381 - 391
  • [10] Real-world first-line (1L) treatment patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in a US health insurance database.
    Swami, Umang
    Hong, Agnes
    El-Chaar, Nader N.
    Nimke, David
    Ramaswamy, Krishnan
    Bell, Elizabeth J.
    Sandin, Rickard
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345